港股異動 | 微創腦科學(02172)再跌超7% 較月內高點已跌25% 公司全年純利同比增長近75%

智通財經網

03-27

微創腦科學(02172)績後跌超7%，較月內高點15.24港元已下跌約25%，截至發稿，跌5.64%，報11.72港元，成交額2792.35萬港元。

消息面上，微創腦科學發佈年度業績，收入7.62億元人民幣，同比增加14.44%；權益股東應占溢利2.54億元，同比增加74.63%；每股基本盈利0.44元；擬派發末期股息每股0.11港元。

公告稱，收益增加主要由於海外業務實現突破性進展，報告期內收入較上年同期提升137.6%，貢獻集團收入增量；腦動脈粥樣硬化狹窄產品持續提升市場份額，實現收入顯著增長；彈簧圈產品得益於集採中標，加快空白市場開拓，對收入增長起到重要作用；近年來獲批上市的多款急性缺血性腦卒中產品加速醫院准入和臨牀使用，貢獻集團收入增量。

海量資訊、精準解讀，盡在新浪財經APP

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2522987303"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2522987303\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2522987303?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-03-27 09:55","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2522987303","market":"hk","top_or_hot":-1,"title":"港股異動 | 微創腦科學(02172)再跌超7% 較月內高點已跌25% 公司全年純利同比增長近75%","media":"智通財經網","content":"<html><body><div>\n<p cms-style=\"font-L\"><span><a href=\"https://laohu8.com/S/02172\">微創腦科學</a></span><span></span>(02172)績後跌超7%，較月內高點15.24港元已下跌約25%，截至發稿，跌5.64%，報11.72港元，成交額2792.35萬港元。</p><p cms-style=\"font-L\">消息面上，微創腦科學發佈年度業績，收入7.62億元人民幣，同比增加14.44%；權益股東應占溢利2.54億元，同比增加74.63%；每股基本盈利0.44元；擬派發末期股息每股0.11港元。</p><p cms-style=\"font-L\">公告稱，收益增加主要由於海外業務實現突破性進展，報告期內收入較上年同期提升137.6%，貢獻集團收入增量；腦動脈粥樣硬化狹窄產品持續提升市場份額，實現收入顯著增長；彈簧圈產品得益於集採中標，加快空白市場開拓，對收入增長起到重要作用；近年來獲批上市的多款急性缺血性腦卒中產品加速醫院准入和臨牀使用，貢獻集團收入增量。</p>\n<div></div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量資訊、精準解讀，盡在新浪財經APP</div>\n</div>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股異動 | 微創腦科學(02172)再跌超7% 較月內高點已跌25% 公司全年純利同比增長近75%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股異動 | 微創腦科學(02172)再跌超7% 較月內高點已跌25% 公司全年純利同比增長近75%\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">智通財經網</strong><span class=\"h-time small\">2025-03-27 09:55</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<p cms-style=\"font-L\"><span><a href=\"https://laohu8.com/S/02172\">微創腦科學</a></span><span></span>(02172)績後跌超7%，較月內高點15.24港元已下跌約25%，截至發稿，跌5.64%，報11.72港元，成交額2792.35萬港元。</p><p cms-style=\"font-L\">消息面上，微創腦科學發佈年度業績，收入7.62億元人民幣，同比增加14.44%；權益股東應占溢利2.54億元，同比增加74.63%；每股基本盈利0.44元；擬派發末期股息每股0.11港元。</p><p cms-style=\"font-L\">公告稱，收益增加主要由於海外業務實現突破性進展，報告期內收入較上年同期提升137.6%，貢獻集團收入增量；腦動脈粥樣硬化狹窄產品持續提升市場份額，實現收入顯著增長；彈簧圈產品得益於集採中標，加快空白市場開拓，對收入增長起到重要作用；近年來獲批上市的多款急性缺血性腦卒中產品加速醫院准入和臨牀使用，貢獻集團收入增量。</p>\n<div></div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量資訊、精準解讀，盡在新浪財經APP</div>\n</div>\n</div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-27/doc-inerachv8265382.shtml\">智通財經網</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1100","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-03-27/doc-inerachv8265382.shtml","article_id":"2522987303","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522987303","pubTimestamp":1743040500,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"微創腦科學績後跌超7%，較月內高點15.24港元已下跌約25%，截至發稿，跌5.64%，報11.72港元，成交額2792.35萬港元。消息面上，微創腦科學發佈年度業績，收入7.62億元人民幣，同比增加14.44%；權益股東應占溢利2.54億元，同比增加74.63%；每股基本盈利0.44元；擬派發末期股息每股0.11港元。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1100":"医疗保健设备","02172":"微创脑科学"},"translate_title":"Changes in Hong Kong stocks MicroPort Brain Sciences (02172) fell more than 7% again, falling 25% from the month's high. The company's full-year net profit increased by nearly 75% year-on-year.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02172":1},"content_text":"微創腦科學(02172)績後跌超7%，較月內高點15.24港元已下跌約25%，截至發稿，跌5.64%，報11.72港元，成交額2792.35萬港元。消息面上，微創腦科學發佈年度業績，收入7.62億元人民幣，同比增加14.44%；權益股東應占溢利2.54億元，同比增加74.63%；每股基本盈利0.44元；擬派發末期股息每股0.11港元。公告稱，收益增加主要由於海外業務實現突破性進展，報告期內收入較上年同期提升137.6%，貢獻集團收入增量；腦動脈粥樣硬化狹窄產品持續提升市場份額，實現收入顯著增長；彈簧圈產品得益於集採中標，加快空白市場開拓，對收入增長起到重要作用；近年來獲批上市的多款急性缺血性腦卒中產品加速醫院准入和臨牀使用，貢獻集團收入增量。\n\n\n\n海量資訊、精準解讀，盡在新浪財經APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}